Baillie Gifford & Co. Has $16.60 Million Stake in Marsh & McLennan Companies, Inc. $MMC

Baillie Gifford & Co. lowered its position in Marsh & McLennan Companies, Inc. (NYSE:MMC) by 11.1% in the third quarter, HoldingsChannel.com reports. The fund owned 82,361 shares of the financial services provider’s stock after selling 10,287 shares during the quarter. Baillie Gifford & Co.’s holdings in Marsh & McLennan Companies were worth $16,598,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of MMC. Brighton Jones LLC increased its position in Marsh & McLennan Companies by 51.2% during the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after buying an additional 2,960 shares during the last quarter. Bison Wealth LLC boosted its stake in shares of Marsh & McLennan Companies by 39.6% during the 4th quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after acquiring an additional 869 shares during the period. Norden Group LLC increased its holdings in shares of Marsh & McLennan Companies by 5.5% during the 2nd quarter. Norden Group LLC now owns 971 shares of the financial services provider’s stock worth $212,000 after acquiring an additional 51 shares during the last quarter. Perigon Wealth Management LLC raised its stake in Marsh & McLennan Companies by 41.9% in the 2nd quarter. Perigon Wealth Management LLC now owns 15,337 shares of the financial services provider’s stock valued at $3,353,000 after acquiring an additional 4,529 shares during the period. Finally, Novem Group bought a new position in Marsh & McLennan Companies during the second quarter worth $823,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Marsh & McLennan Companies Price Performance

Marsh & McLennan Companies, Inc. has a 52 week low of $174.18 and a 52 week high of $248.00. The business’s 50 day moving average is $183.69 and its two-hundred day moving average is $194.05. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.12 and a current ratio of 1.12. The company has a market cap of $89.35 billion, a price-to-earnings ratio of 21.87, a PEG ratio of 2.87 and a beta of 0.76.

Marsh & McLennan Companies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Thursday, January 29th will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Thursday, January 29th. This represents a $3.60 annualized dividend and a yield of 2.0%. Marsh & McLennan Companies’s dividend payout ratio is 43.17%.

Insiders Place Their Bets

In related news, CEO John Q. Doyle sold 21,079 shares of the company’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $182.22, for a total transaction of $3,841,015.38. Following the sale, the chief executive officer directly owned 87,681 shares in the company, valued at approximately $15,977,231.82. This represents a 19.38% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.35% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

MMC has been the topic of several research analyst reports. Royal Bank Of Canada began coverage on shares of Marsh & McLennan Companies in a research report on Tuesday, November 25th. They issued a “sector perform” rating and a $200.00 price objective on the stock. JPMorgan Chase & Co. decreased their price target on shares of Marsh & McLennan Companies from $242.00 to $226.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 7th. Weiss Ratings restated a “hold (c)” rating on shares of Marsh & McLennan Companies in a research report on Friday, October 31st. Keefe, Bruyette & Woods upped their target price on Marsh & McLennan Companies from $191.00 to $205.00 and gave the company a “market perform” rating in a research report on Tuesday, January 6th. Finally, UBS Group dropped their price target on Marsh & McLennan Companies from $258.00 to $257.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Eight equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Marsh & McLennan Companies has an average rating of “Hold” and a consensus price target of $218.82.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.